
Rheumatoid Arthritis Studies Auckland (1)
Auckland
Are you living with Rheumatoid Arthritis and searching for alternative options? Momentum Clinical Research is conducting a clinical research study evaluating an investigational treatment designed to address joint inflammation.
By joining, you may receive early access to a potential new treatment, receive regular study-related health checks, and help contribute to research that could benefit others living with Rheumatoid Arthritis.
Description
What to expect
Ages
18-75 years old
Duration
The study duration is up to 12 weeks, with regular follow-up days. For Part A of the study, this includes a screening period of up to 28 days, one inpatient clinic stay, and several outpatient follow-up visits.
Compensation
Participants will be paid for time and study-related costs.
Eligibility Criteria
You may qualify for this study if you:
Other criteria will apply.
Locations
Rheumatoid Arthritis is a long-term condition where the bodies immune system accidentally attacks healthy joints, causing persistent inflammation, swelling, and pain.
Frequent joint flare-ups can severely restrict daily movement, diminish strength, disrupt work capabilities, and impact overall well-being. While standard medications exist, many individuals do not respond fully to current options and experience continuous symptoms, presenting a significant need for new approaches.
This first-in-human study is evaluating the safety, tolerability, and dosing of an investigational study treatment, given as an injection under the skin. The treatment is designed to temporarily lower a specific type of overactive immune cell that drives joint damage and swelling. The main goal is to understand how the treatment acts in the body and evaluate its ability to reduce joint inflammation and support long-term relief.
All study-related medical assessments, tests and procedures are provided at no cost. Participants will be compensated for time and study-related costs.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. By submitting this form you agree to our Privacy Policy which contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.